Received: from DM3NAM03HT192.eop-NAM03.prod.protection.outlook.com
 (2603:1096:a00:1::20) by MAXPR0101MB2074.INDPRD01.PROD.OUTLOOK.COM with HTTPS
 via MA1PR01CA0104.INDPRD01.PROD.OUTLOOK.COM; Tue, 9 Jan 2018 12:36:32 +0000
Received: from DM3NAM03FT005.eop-NAM03.prod.protection.outlook.com
 (10.152.82.53) by DM3NAM03HT192.eop-NAM03.prod.protection.outlook.com
 (10.152.83.82) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA384_P256) id 15.20.345.19; Tue, 9
 Jan 2018 12:36:30 +0000
Authentication-Results: spf=pass (sender IP is 104.47.100.47)
 smtp.mailfrom=medicinalsciences.com; outlook.com; dkim=pass (signature was
 verified) header.d=NETORGFT2521745.onmicrosoft.com;outlook.com;
 dmarc=bestguesspass action=none header.from=medicinalsciences.com;
Received-SPF: Pass (protection.outlook.com: domain of medicinalsciences.com
 designates 104.47.100.47 as permitted sender)
 receiver=protection.outlook.com; client-ip=104.47.100.47;
 helo=IND01-MA1-obe.outbound.protection.outlook.com;
Received: from IND01-MA1-obe.outbound.protection.outlook.com (104.47.100.47)
 by DM3NAM03FT005.mail.protection.outlook.com (10.152.82.143) with Microsoft
 SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA384_P256) id 15.20.345.5 via
 Frontend Transport; Tue, 9 Jan 2018 12:36:29 +0000
X-IncomingTopHeaderMarker: OriginalChecksum:F6E5FF9E219C0B1178D8ECB0C4EFEABC89A662605367E794BB4B34B82365FDFC;UpperCasedChecksum:3C04C5A17475FC6CAAFD2C21293199156EE926860A27FCC1164D02F14FE32103;SizeAsReceived:8274;Count:39
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
 d=NETORGFT2521745.onmicrosoft.com; s=selector1-medicinalsciences-com;
 h=From:Date:Subject:Message-ID:Content-Type:MIME-Version;
 bh=6R3j2xy/eAaqm7ZpR2whuDVRsCevdbOUh80jrmpSb2U=;
 b=qrIPoPQMMa6sAEmO7fQreNmV/3QBg1pC6q7yF6cuY0iNltbJHICdghcHGRtneWYbxmt6ZBPZxd58Vojf4INyg8ofWdZVz63HkQSU18z5guG+5hadrYnpPcJQuXlbTPm/CloWAXDKzH07P2rW/gSZT1VE5ES4j9kBz1DKGUbLTRE=
Authentication-Results-Original: spf=none (sender IP is )
 smtp.mailfrom=braindisorder@medicinalsciences.com; 
Received: from sysPC (125.99.159.211) by
 MA1PR01MB0599.INDPRD01.PROD.OUTLOOK.COM (10.164.122.22) with Microsoft SMTP
 Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA384_P256) id
 15.20.366.8; Tue, 9 Jan 2018 12:36:26 +0000
From: <braindisorder@medicinalsciences.com>
To: <xiangzhen.kong@outlook.com>
Subject: RE: Reminder for your Contribution 
Date: Tue, 9 Jan 2018 18:06:46 +0530
Message-ID: <!&!AAAAAAAAAAAYAAAAAAAAAIoTk9JACJhFslgdgX1r9TzCgAAAEAAAAHVR03u/lZ1MkE38LQZlsPcBAAAAAA==@medicinalsciences.com>
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_0078_01D38974.9E75AC80"
X-Mailer: Microsoft Office Outlook 12.0
Thread-Index: AdOJRoHnAVfDtoyLS9uS+C97Sl9rQw==
Content-Language: en-us
Disposition-Notification-To: <braindisorder@medicinalsciences.com>
X-Originating-IP: [125.99.159.211]
X-ClientProxiedBy: BM1PR0101CA0042.INDPRD01.PROD.OUTLOOK.COM (10.174.221.28)
 To MA1PR01MB0599.INDPRD01.PROD.OUTLOOK.COM (10.164.122.22)
Return-Path: braindisorder@medicinalsciences.com
X-MS-PublicTrafficType: Email
X-MS-Office365-Filtering-Correlation-Id: 07ce841f-ded3-4e12-dd40-08d5575d9bf3
X-Microsoft-Antispam-Untrusted: UriScan:;BCL:0;PCL:0;RULEID:(4534020)(4602075)(4627115)(201703031133081)(201702281549075)(5600026)(4604075)(2017052603307)(7153060)(7193020);SRVR:MA1PR01MB0599;
X-Microsoft-Exchange-Diagnostics-untrusted: 1;MA1PR01MB0599;3:xhFR78PnENB1L0JLC+rjpyVrU3FH10FTIdJW99U3hLR2DmzAlNQOxg8hOXlhY4v3xtBoYnaYFXioWdumc2Hc3Y3tJ6LH6qS24OG/1gzXDIMP29NjG0C6ZUFr+CfrBMfZwljCNyy34sB9aoIrFgA6LqdGCyU2ilDNRDgafFaxiZZYgtPO9PPD/dg5S1nF+PiTjm8Zzdwy0FJ8CG+Pyep0nmHdj9Y7zJJ0LSyjaT9kYNQvOxlJ7sxUIu0qTIXzDayE;25:i/JJrV5CvsMeIJ1Q9Em06MNhdD62ZyCiP7rHGiyH2T9au3XO21VEDIe6oLBYXmPJsmqIGB4YU7iTtS3+5E08RRimRm7dQEoLh5vJZAm66YvEQRtULVv4JAAzbF0UcLFTNyceXvprDjI0UM+Vf7z7ymlqY5kACpucEseLuoigjTYvQVX+qn4EKvmFTFt9ox+VyVumBCzg5YzzOCZAP/txh/csPZqWY7pQ47moPro8jGKSIYX5sl8o/3+Tnzns0V7QsxpEB87woqxosaOf7NvJysDiNkvi2MOI+L0QXiUG/Xv0xnnQ6hykMaN0h60IV3I76aNxuj+AErcXkjhJOoBBHw==;31:NVNZ+1Hx0md4GW+y+xGqQPd7+f6BYul2m5VnSMCDe4UrsDdhIZcUXXvpMlUzyl6Q5EE9owPTXb3hjSoLiHFvcV3JLiDJcPEMt+spIWcGL2O7YwGeSFu/fQ4EbEB3BH9k5kjuLJaq6RORJTXpMing6hR56Jckmop8Uwh2+TP8ge1rB3Okp7pIkJvdBMNb2E77/O32GNZDdalAP+lHOsLrH3g22plArBz6DzrJrn3Dvq8=
X-MS-TrafficTypeDiagnostic: MA1PR01MB0599:|DM3NAM03HT192:
X-Microsoft-Antispam-PRVS: <MA1PR01MB059907B59D06664A45DB0BDEB8100@MA1PR01MB0599.INDPRD01.PROD.OUTLOOK.COM>
X-Exchange-Antispam-Report-Test: UriScan:(28532068793085)(209352067349851)(21748063052155);UriScan:(28532068793085)(209352067349851)(21748063052155);
X-Exchange-Antispam-Report-CFA-Test: BCL:0;PCL:0;RULEID:(6040470)(2401047)(5005006)(8121501046)(10201501046)(3002001)(93006095)(93001095)(3231023)(944501075)(6041268)(20161123558120)(201703131423095)(201702281528075)(20161123555045)(201703061421075)(201703061406153)(20161123560045)(20161123564045)(20161123562045)(6072148)(201708071742011);SRVR:MA1PR01MB0599;BCL:0;PCL:0;RULEID:(100000803101)(100110400095);SRVR:MA1PR01MB0599;BCL:0;PCL:0;RULEID:(444111537)(595095)(82015058);SRVR:DM3NAM03HT192;BCL:0;PCL:0;RULEID:(100000803101)(100110400095);SRVR:DM3NAM03HT192;
X-Microsoft-Exchange-Diagnostics-untrusted: 1;MA1PR01MB0599;4:qQQkJ7jCL6t6+khLyDuCCS2oe4BVVK1bO85X8tNDWNuT8c5x7mlGVNotvv+U/WVxvdHc5G9fQW7rWDA/PdH2LlWoqo5U319r3XXnVR2Sirm3vhOoTjV72kN8IRdjDC9kmyIcxjV/6ipUaw4vmE7QoyoYVBcwLTbzJpRfwouUSDIgvoAHvS9eWyNEUp05yUDibqntlz0lOXw2/OmAggD8Tm9EI72QMDrpRNyjx/e90DvSyEIeQV9unJPhA7cXk+INDTzMPD1dYit7kOosnYXWajgezMGs8uzG1bQWg3Eyn16xeQ+JhcCgENFWUY4JUHBWgFGlDa/45TMCRebVm2j8Pm9yIKu0/JnejcGDJENCMuzwJwgr5NsPfBO4oLgVTzgx
X-Forefront-PRVS: 0547116B72
X-Forefront-Antispam-Report-Untrusted: SFV:NSPM;SFS:(10009020)(39840400004)(39380400002)(376002)(396003)(346002)(366004)(199004)(189003)(84964002)(12213003)(626008)(84326002)(3846002)(81166006)(53936002)(3480700004)(97736004)(81156014)(8676002)(316002)(50226002)(6246003)(39060400002)(53376002)(36756003)(966005)(6116002)(790700001)(478600001)(2876002)(16526018)(86152003)(4743002)(6306002)(68736007)(8936002)(16586007)(66066001)(229853002)(18717965001)(236005)(6486002)(54896002)(6666003)(2351001)(386003)(6496006)(86362001)(105586002)(52116002)(106356001)(6916009)(270700001)(260700001)(61296003)(7826002)(88246002)(606006)(7736002)(25786009)(2906002)(5660300001)(14726001)(102836004)(71636004)(60100200001);DIR:OUT;SFP:1101;SCL:1;SRVR:MA1PR01MB0599;H:sysPC;FPR:;SPF:None;PTR:InfoNoRecords;A:1;MX:1;LANG:en;
Received-SPF: None (protection.outlook.com: medicinalsciences.com does not
 designate permitted sender hosts)
X-Microsoft-Exchange-Diagnostics-untrusted: =?us-ascii?Q?1;MA1PR01MB0599;23:2CpSTjZsK/gGfCBvfjDfRUtOtfewH31vSKeX9gtmW?=
 =?us-ascii?Q?O2NEo97CpYWXS72lNFuvAjJTetHUQHNpSV2p1dRE4MXg/JY+4aveRZJlG3Y8?=
 =?us-ascii?Q?JcyUIS1VeHVjgYyzeS4YJgXeceATYYNCexO/deLUIZojsdYaNvOBl3fZayvG?=
 =?us-ascii?Q?HO988YmFgzhir8e79god34IZM7xjXU4P/Mhm1M4kYLd5HaZ6UycX9fYGHoku?=
 =?us-ascii?Q?1AxUeujDLm/s3hVO97xRcJ1Jvbm8KCgwsFHxMszLU34vFUFWlB9utkI9njde?=
 =?us-ascii?Q?12sc6SFk0puYcnkjHVtS5H+g+fStmOC7UyrJugJM9tSG3GTfyYdC0n9DBtST?=
 =?us-ascii?Q?hJyh7c1MyV0pNpkL/ETURreVlw3aR9/ted6xD+SmbkfzcAFl7uVDKImjjUd5?=
 =?us-ascii?Q?O16bOvwgci9h4WmcgV6KqJlFJjWVQaeu+QEcReltj10DrvGWafAm2yewe/6b?=
 =?us-ascii?Q?smIgTUZdENHfDXTiKWZ5bho5PC0ms2fnSzB4wqt1Xm1yx0G+nvtWOMRTRhTY?=
 =?us-ascii?Q?kLtNIq3Sr8Lpnoqnxnrjs9FEUnJMqvgSj46zoY05E084YkO2jjubsrYrUMh6?=
 =?us-ascii?Q?PZVSjLgvxGttPD2dEukKIxHqcw6iK0o2e3jLRm3gA2g6oeNnH4p4bSSygAhv?=
 =?us-ascii?Q?vD6pLnVTqMoIPAI2jwOKdsUKgVX51gJPAIjpnnT5lmImCQqij5eqghaE+r67?=
 =?us-ascii?Q?hGBY/ewGIjAV7lTHvdwZawC1K4NDYiM9Umqrc7YiWYwDw4Q+gVtrbzj5WkbY?=
 =?us-ascii?Q?GeMjyTWDiJl+iWqqd44oFN6MyL4VEJLyvsYTjrCUhZhEUeKJ/x/WWxqiQlw0?=
 =?us-ascii?Q?C4P4WF1SHTTG6RJA9q+Q0vKpV8k/fpuk4VjtzJqfQHRo9hR7M38grU2HL579?=
 =?us-ascii?Q?Pc1Gh216BDCaAHANjtDPfUM0ACLG3DG2fBSFKogKxQydWpeX8fE+qFmWrQ+4?=
 =?us-ascii?Q?gZv0noQoC2LE/DT8QYidJh3NgaDvz4G5VRpTDgpYpkT/ozFLZVq0n0JPqD0R?=
 =?us-ascii?Q?2S6ao8uAMz5RHrqVaA+ZV4FE14YyjTHhiz60/Hb5WXk4QwnTDOyF3QFWbO8c?=
 =?us-ascii?Q?/+J+s9CFp0CPxWY1payCQzYbQLf5VwSP+xX7uEOcHaWUOxAiCLIrnt4VH5ep?=
 =?us-ascii?Q?tmtEnF0ag3qpAY9X2Bnh4z9kqreaJbzXugyfr4tJDsInCa+0aS9Rbj+5xzgi?=
 =?us-ascii?Q?X56NTW3xdqhnY/e393nGyyL4zPzyQajIkc/+rxpwk9SoCOOt9y+S/Qh5eE6u?=
 =?us-ascii?Q?XeH3J72CS2MpcY0jJoNJXb9n5Zyo+SGLfUH+EP/vZjEan4/hj06LikMoYXaq?=
 =?us-ascii?Q?ca3+FQ8cCaSb369xWRIGkI2J7g3Is/UzAotkPAomCIQWKafexd4K2AonwNZk?=
 =?us-ascii?Q?x9gkq4XQ27acat8uEicEGDxPV1xrmEaaHCTtqWjkEDRqnkGXz0ITpqYIu8/V?=
 =?us-ascii?Q?Fh6xUESE+8THp1GWc9cT79qsgAbeda43c0eZ0DkK55xJZqAd2fFiYGpkC82W?=
 =?us-ascii?Q?ZnjnXu5r1lO+A=3D=3D?=
X-Microsoft-Exchange-Diagnostics-untrusted: 1;MA1PR01MB0599;6:fU9ZY7G8x4axVm6461IQDciZwUqVXi5bepdEA3ASIE5kXUq48NgsjMGVhDYwtMFNJ10HR/Ah1qmqqN2OWbU2mEYY18zgsSn9GRO0p19CrCSkRF1QtgLilL7nJpIxVSG7zlPtju9igUmsRPAp7dcF/dr40YIAHVfWTUcvrpgKwD0I6p4K+ub809RShTRyww8DjCEHaZ+Od77WXst3FgwZVMYz1y7DDYie9FOhbDQ6chcmAs7o5/fsSe7JRkXksssoBiLZzhdQz4lZSrGUKTANKKnK3lbBF1juiRFEgCtmWt3zwrwH2P+cO5WTY3kng1IrhbvW/4LKHYm7RXiu20ZiAbjfYjQ10eebrykItf5/9MY=;5:bVXxpBlpFSaH092s3vJHp3pGBQUa8wa6xM8phRvgmol8EBRmZ9RYduZnEE+zXDFgSUQ/supbuB8Bhl+43iHyMezfVlbrJkdyYSaDyo6VMb31SEXIyREU38MYzyXpmYNwRnQY7FmNmjCNl7f8MGL+9hFV/FNlWAxc5GnZ0crLZ1w=;24:1L1IxEG9f2tY+1kAUb6cr0PkiQizY2AUsQOSCj/+y+V5s7+frgr1jWym3uaWvQ2aUrga2ZjGj4xMS91dXZXmoE7vAhIFCwJBTpScNSl1cio=;7:IBuFUy7jLRtlvotnHmAHQVJKpnsUjQOQaDOU434GJzO+1ZoCAPL801agPjZZkefYJEZxkoJVOftceT4NtsXrovjQIuHLUGHcW4C3mL1nAU+jH9CPJG5h6KWlXV+uPLwSj8l6YUy3ZY92om8gZu7FAJfNnFi9vhB2IOvm0lbegwoFv42aOPp/Lf97vi8sgzy/zubt8ce1Kzp5RWyTyAJQWB0FknAeVSNVejK5Q++V60w5gVj0HxpY51ALcEU6C6XE
SpamDiagnosticOutput: 1:99
SpamDiagnosticMetadata: NSPM
X-MS-Exchange-Transport-CrossTenantHeadersStamped: MA1PR01MB0599
X-IncomingHeaderCount: 39
X-MS-Exchange-Organization-Network-Message-Id: 07ce841f-ded3-4e12-dd40-08d5575d9bf3
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 84df9e7f-e9f6-40af-b435-aaaaaaaaaaaa:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-Exchange-Transport-CrossTenantHeadersStripped: DM3NAM03FT005.eop-NAM03.prod.protection.outlook.com
X-Microsoft-Exchange-Diagnostics: 1;DM3NAM03FT005;1:hB2iVOhg1C5e1vVuWVThRqYCqI8ORCEm9V04tkFyzYOThpiqQOmqrLcP13bgQCIKu0LzcB+gi+KRzpeMcvNu1mz8LcLiwHt5QNV6pAG3UxYc/FaVXeTuM70Z7hBCH1Zc
X-Forefront-Antispam-Report: EFV:NLI;SFV:NSPM;SFS:(98901004);DIR:INB;SFP:;SCL:1;SRVR:DM3NAM03HT192;H:IND01-MA1-obe.outbound.protection.outlook.com;FPR:;SPF:None;LANG:;
X-MS-Exchange-Organization-AuthSource: DM3NAM03FT005.eop-NAM03.prod.protection.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-Microsoft-Antispam: BCL:0;PCL:0;RULEID:(5000109)(4604075)(4605076)(610169)(650170)(8291501071);SRVR:DM3NAM03HT192;
X-Microsoft-Exchange-Diagnostics: 1;DM3NAM03HT192;3:I1Lz4Fv4aXD/wkSnFjyP8kOVER4ku5TgO0Afk3fsmYK/aF29+u3XY5zMi4RwgQNaZcMgX7tB9ct4KuyjeSj0ap9pH2XMQHFMxkWQen3PbScrIu6iyfwmPYL+JJ4ZjL2tUbbN5wfJmGrakcdorDvhCqw6m2iWt7wRmGCBju1z4kWWW2cispAqCfRf6D35TmSu0NZGnTr2/+/CFoHWrjZKZtlkuZrKy8PUVweCLQeG+3KQ+Jk84tZwbMBWCo3gpBcAMocBFaoK56/VsPFbhFi3QjHQVKxxjB2DGVb5a13T8/UPULXUtqCS4Aj+hux1geeW;25:XKWJjul9CuVIRfIP/komUecwYJGIgZ0UzTVQc1J+/t/HPQDFoWow6ZWdyIy0jy9DTBXUfDpK+Ssjz1uzK2gPGlLCVcXgvkVXPo8N+W6aB9SU0cVZkvhSLpBLIwSyJz+DrMffp3uPW38Ucf/lkl/9P8Fo0PWkvfcf7/LeUzNM9wjuABk5ullOtSfjP2Bzqg5J431pG7Uiop9bDbYx4vgdhfdF6zAQNXkJsvtD0aod7P/oBj6b7nUPcgRqcQvvJN5yRKYiyH05r8DJDIfSv2ImeiXxWd8NxnWqALGifjQCIWZTsVHJGUJG8icyKXfraimThIVNmWvyCk5wVnlFGn3TIg==;31:8D/M5xn5+DmNU371/0/e7EX67AuBa0ACqOYYVyr3A4ROGCtUJ1kBL++3vzQBOAZ+BdPhIhxTvJZh5T2lskq+YPbWYoWk2P6dXC3T6Gextqh48fV4W6GRVbb74WITCN7gwfnmfHTiwHiL3Zayjkre8GWCO16ko3jnmNOeeT2R+t0aBFfrkKoqiJclVxGDUdNWqbQNjeBOiNNbEYBfaZuqyomURgErjB7DkpvhNW3rRFg=
X-MS-Exchange-EOPDirect: true
X-Sender-IP: 104.47.100.47
X-SID-PRA: BRAINDISORDER@MEDICINALSCIENCES.COM
X-SID-Result: PASS
X-MS-Exchange-Organization-PCL: 2
X-Microsoft-Exchange-Diagnostics: 1;DM3NAM03HT192;4:8N/3x0WgwBUHaVrBzFfDaALBB0PRml67ukdDVnLSO13xYBChTqH6SKGlS/VFsXm1OgVnTSFvMq+DyRuRUPajwW8Sx5LouhYOX3OnZepMT1a6QN66oAvKhpkZB+xT963q8q+pYNaWAJZyzRKpwgKQOPg8WCo1YE/V5B5PlzRFwAixVwANq4+k/3RW1X0J3KzdRsXKXCSv0a1tj3oYm1tU4Oc/Dc1uOoN1eYe1G3IDmtZOHWFE59+UkIobPUkw3c5CsKQr57n56lmADykDj2D4XRYTxmkELgoon4tL2ev6ph05F6RPO0ECs3O/n7KZKqydLlpRBvd4OVUbFfHqG6o+XMr9VaLqiFSpRPxhQpl6Mg5y15Xrs2JWG09WmfsPM4b7;23:wuRmIa0lFM6GSlTZwCOLfPx5ZNt9JACJ6iANLmTrZ+Wi/qPsjpreraLBhoORAYnGqvEzUUuowo5pH1FxSthBBNZynFT1ho+ZO50T8lqAEW4bqlagcqvw3Cg6PqxDrMT9PKp2A114ysjs167uz/gPmugYIXJs3bpuArF2TupA4OY=;6:BsDE1Qnrr1jT6eDQRGUL6k6f72IC065NJW3d8m972S6WPBSpNpY5veNZ9t/Ubxi9mqem+UvIkALv5TTSyv6KkqqEugbuK+SU0cdrEcKoXX9XzErvO5yXMUgfZ14cM+jcKmcmjL74CuNukvLWErr+epxbFKMadii0wqbkIGe/60VQIvqpp8yyXLoZlT/1mo47aafJqnlYLKdc+lJ81TLeMSYlrMpb/f9MzHLxlXKbG5/VnXuISTl/7nWK/yrDX7oKLZUtpFEZzrHmnisHrfAmDGD2V61CTfFpeR9LQ+kwv78NfVXYw7aR0kIfrAXSx3sGynZuiKy8txJkpn+wDi9ofdFDpMr4VVzeaF/jv0V0T7U=
X-MS-Exchange-Organization-SCL: 1
X-Microsoft-Antispam-Message-Info: WLsd38aDLHvSRlxT7HMYZUxh2MF6j/RiIw+O6g7nSVQa/nq7D1foDir++tJmEHWkRbw6KAceAgsHdyMuQLldWuuI5WjdHh7pUehLbd3KUHQ=
X-Microsoft-Exchange-Diagnostics: 1;DM3NAM03HT192;5:wpppWjzM/5RqmDiSVtPqaVSSSKi7DhgqLBtKWwqcHylZdelajtRLRNkVwVar2ARsDNwqK8yFTpWIvrOlKCxS5Tnt0VgdK26xKNpNO2gMCY0s9gbaAZ9MDZG0MkN0O4Bianocug4zsCpwOwxqG0UwAdEoAnE4Sg1OuTBm3isPBio=;24:cohOWoBrub6U+1VxHckxbXaQBxM1IsxONYDPuMP5FV8PN0pjP/GxTKJgbIeALDojwBR95jKyj0Ob2v9ksZEKdoLU0TaGlREJ9dsNYAtrGcc=;7:R/TSAlBS1pR9GrP0SVKH5BWAcE6YsEDhKjGNcVXBSEOp8hshg08c3Puhkpecrg97QpjznpyBYn2TLPPIrbEMXguwLmuX+32qJ0dn0uGbaJtWw26/iZpLTytjTlewK0vOXSjc5Pjhfa69SHNGtuHv/sMpQcPejK2ODqq65FyMvfE2CgTCurqft6sZqyEN3Eb1mhy8pEVvRATQgkJvstIh38Q6fz37/xsmIzLThpD1JCQVh5FKNRqinC0JPhus6tSB
X-OriginatorOrg: outlook.com
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 09 Jan 2018 12:36:29.7662
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 07ce841f-ded3-4e12-dd40-08d5575d9bf3
X-MS-Exchange-CrossTenant-Id: 84df9e7f-e9f6-40af-b435-aaaaaaaaaaaa
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: DM3NAM03HT192
X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.5247951
X-MS-Exchange-Processed-By-BccFoldering: 15.20.0386.009
X-Microsoft-Exchange-Diagnostics:
	1;MAXPR0101MB2074;27:EPMVH3s7KlBF3ARwMy2b/DSzD+ZPJO4BdOQBXL/EYHOmezbHiMxpEtSDCI9OrLIhgKMNfdN6uCMlnNASZheN9WACGd8zB6hwM6V6N3zluxoW8excR4uQmIiDAmyblWlO
X-Microsoft-Antispam-Mailbox-Delivery:
	abwl:0;wl:0;pcwl:0;kl:0;iwl:0;dwl:0;dkl:0;rwl:0;ex:0;auth:1;dest:J;ENG:(400001000128)(400125000095)(5062000261)(5061607266)(5061608174)(4900095)(4920089)(6375004)(4950112)(4990090)(9140004);RF:JunkEmail;OFR:SpamFilterAuthJ;
X-Message-Info:
	qoGN4b5S4yqAQX11CXTbGTH3hQj0juf5tf3zCibN4pb5BM0QCJkvVDiSoDvK6aiQK3xyhNfipgCV6CKq051LNsgAtEJA19ysfcIURInfT13qYBZf0gGQF2rT3EMSHhLcBLsBrc8+kAdX/B1AG3e8ly4K5suUc06PYBmU1nCmiWVRu84Kv3EEXYosIvMiSmM/0IZMZosTIro=
X-Message-Delivery: Vj0xLjE7dXM9MDtsPTA7YT0wO0Q9MjtHRD0yO1NDTD02
X-Microsoft-Antispam-Message-Info:
	mxY95EKcfrUWYuEr2aEuf31An95CU5F/PkJy1eLGdL9B+9I2b3mpp5flEXIyJADZMkUxkrWOgrZK76IyYx+2tG+xNnFQtISoWhh8JjQ4C7OqhHlAPt3dbkkk0LNJLv5zOr5liUKMPRsEF3mJkN9ilpUUXSq5b48UGx43WeZc8TTK4On5Vt+FkeIsN3VY/MY19IWv+Vm1Ta5SoP4CvhmFKoawJg1SJ/Pbg+ucaJJ2KIh2Nh0lDhBHvoVVWxBm86sWWUYa8aNhdZC/pJfYjFtooA==
MIME-Version: 1.0

------=_NextPart_000_0078_01D38974.9E75AC80
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit
X-Microsoft-Exchange-Diagnostics:
	1;MAXPR0101MB2074;27:EPMVH3s7KlBF3ARwMy2b/DSzD+ZPJO4BdOQBXL/EYHOmezbHiMxpEtSDCI9OrLIhgKMNfdN6uCMlnNASZheN9WACGd8zB6hwM6V6N3zluxoW8excR4uQmIiDAmyblWlO
X-Microsoft-Antispam-Mailbox-Delivery:
	abwl:0;wl:0;pcwl:0;kl:0;iwl:0;dwl:0;dkl:0;rwl:0;ex:0;auth:1;dest:J;ENG:(400001000128)(400125000095)(5062000261)(5061607266)(5061608174)(4900095)(4920089)(6375004)(4950112)(4990090)(9140004);RF:JunkEmail;OFR:SpamFilterAuthJ;
X-Message-Info:
	qoGN4b5S4yqAQX11CXTbGTH3hQj0juf5tf3zCibN4pb5BM0QCJkvVDiSoDvK6aiQK3xyhNfipgCV6CKq051LNsgAtEJA19ysfcIURInfT13qYBZf0gGQF2rT3EMSHhLcBLsBrc8+kAdX/B1AG3e8ly4K5suUc06PYBmU1nCmiWVRu84Kv3EEXYosIvMiSmM/0IZMZosTIro=
X-Message-Delivery: Vj0xLjE7dXM9MDtsPTA7YT0wO0Q9MjtHRD0yO1NDTD02
X-Microsoft-Antispam-Message-Info:
	mxY95EKcfrUWYuEr2aEuf31An95CU5F/PkJy1eLGdL9B+9I2b3mpp5flEXIyJADZMkUxkrWOgrZK76IyYx+2tG+xNnFQtISoWhh8JjQ4C7OqhHlAPt3dbkkk0LNJLv5zOr5liUKMPRsEF3mJkN9ilpUUXSq5b48UGx43WeZc8TTK4On5Vt+FkeIsN3VY/MY19IWv+Vm1Ta5SoP4CvhmFKoawJg1SJ/Pbg+ucaJJ2KIh2Nh0lDhBHvoVVWxBm86sWWUYa8aNhdZC/pJfYjFtooA==

Research Advances in Brain Disorders and Therapy

 

Dear Dr. XiangZhen Kong,

 

Hope you are doing well!

 

This is a follow up mail from the editorial office of Research Advances in
Brain Disorders and Therapy.

 

We have contacted you before through mail might be of technical problem you
did not receive it, hence we are taking liberty to reminding you once again
regarding our previous invitation to submit. We would be glad to know your
opinion in submitting your manuscript to the Inaugural Issue, 2018 of the
journal, so we can plan accordingly to include it in the same.

 

Note: We expect your kind opinion please!

 

Please submit your manuscript online at
<https://gavinpublishers.com/journals/submitmanuscript>
https://gavinpublishers.com/journals/submitmanuscript

 

All published articles will be provided with digital object identifier
(DOI).

 

Hope I can hear your voice soon. Looking forward to hearing from you

 

Thanks & Regards,

Lucy Charter | Editor

Gavin International Conferences and Publishers Inc., 

5911 Oak Ridge Way,

Lisle, IL 60532, USA.

Tel: +1-630-397-0234,

Website:  <http://gavinpublishers.com/> http://gavinpublishers.com/

 

NOTE: If you are interested to join as Editor/Reviewer, kindly submit your
CV.

 

 

Disclaimer: You have received this email because of your eminence and
expertise. However, if you do not want to receive any email in the future
from Research Advances in Brain Disorders and Therapy, then please reply us
with the subject "unsubscribe/remove".

 


------=_NextPart_000_0078_01D38974.9E75AC80
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: quoted-printable
X-Microsoft-Exchange-Diagnostics:
	1;MAXPR0101MB2074;27:EPMVH3s7KlBF3ARwMy2b/DSzD+ZPJO4BdOQBXL/EYHOmezbHiMxpEtSDCI9OrLIhgKMNfdN6uCMlnNASZheN9WACGd8zB6hwM6V6N3zluxoW8excR4uQmIiDAmyblWlO
X-Microsoft-Antispam-Mailbox-Delivery:
	abwl:0;wl:0;pcwl:0;kl:0;iwl:0;dwl:0;dkl:0;rwl:0;ex:0;auth:1;dest:J;ENG:(400001000128)(400125000095)(5062000261)(5061607266)(5061608174)(4900095)(4920089)(6375004)(4950112)(4990090)(9140004);RF:JunkEmail;OFR:SpamFilterAuthJ;
X-Message-Info:
	qoGN4b5S4yqAQX11CXTbGTH3hQj0juf5tf3zCibN4pb5BM0QCJkvVDiSoDvK6aiQK3xyhNfipgCV6CKq051LNsgAtEJA19ysfcIURInfT13qYBZf0gGQF2rT3EMSHhLcBLsBrc8+kAdX/B1AG3e8ly4K5suUc06PYBmU1nCmiWVRu84Kv3EEXYosIvMiSmM/0IZMZosTIro=
X-Message-Delivery: Vj0xLjE7dXM9MDtsPTA7YT0wO0Q9MjtHRD0yO1NDTD02
X-Microsoft-Antispam-Message-Info:
	mxY95EKcfrUWYuEr2aEuf31An95CU5F/PkJy1eLGdL9B+9I2b3mpp5flEXIyJADZMkUxkrWOgrZK76IyYx+2tG+xNnFQtISoWhh8JjQ4C7OqhHlAPt3dbkkk0LNJLv5zOr5liUKMPRsEF3mJkN9ilpUUXSq5b48UGx43WeZc8TTK4On5Vt+FkeIsN3VY/MY19IWv+Vm1Ta5SoP4CvhmFKoawJg1SJ/Pbg+ucaJJ2KIh2Nh0lDhBHvoVVWxBm86sWWUYa8aNhdZC/pJfYjFtooA==

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-micr=
osoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"http:=
//www.w3.org/TR/REC-html40"><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii"=
><meta name=3D"Generator" content=3D"Microsoft Word 12 (filtered medium)"><=
style><!--
/* Font Definitions */
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;}
@font-face
	{font-family:"Shonar Bangla";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-priority:99;
	mso-style-link:"Footnote Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";}
span.MsoFootnoteReference
	{mso-style-priority:99;
	vertical-align:super;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-priority:99;
	color:purple;
	text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-priority:99;
	mso-style-link:"Footnote Text";
	font-family:"Calibri","sans-serif";}
span.UnresolvedMention
	{mso-style-name:"Unresolved Mention";
	mso-style-priority:99;
	color:gray;
	background:#E6E6E6;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-priority:99;
	mso-style-link:"Balloon Text";
	font-family:"Tahoma","sans-serif";}
span.m-1152497087464495930gmail-m4099188765937942892apple-converted-space
	{mso-style-name:m_-1152497087464495930gmail-m4099188765937942892apple-conv=
erted-space;}
span.apple-converted-space
	{mso-style-name:apple-converted-space;}
span.m-1152497087464495930gmail-apple-converted-space
	{mso-style-name:m_-1152497087464495930gmail-apple-converted-space;}
.MsoChpDefault
	{mso-style-type:export-only;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:10.0pt;
	line-height:115%;}
/* Page Definitions */
@page
	{mso-endnote-separator:url("cid:header.htm\@01D38974.9B9D3820") es;
	mso-endnote-continuation-separator:url("cid:header.htm\@01D38974.9B9D3820"=
) ecs;}
@page WordSection1
	{size:595.35pt 841.95pt;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]--></head><body lang=3D"EN-US" link=3D"blue"=
 vlink=3D"purple"><div class=3D"WordSection1"><p class=3D"MsoNormalCxSpFirs=
t" align=3D"center" style=3D"text-align:center"><a name=3D"_Hlk484171080"><=
b><u><span style=3D"font-size:14.0pt;font-family:&quot;Georgia&quot;,&quot;=
serif&quot;;color:#263238">Research Advances in Brain Disorders and Therapy=
<o:p></o:p></span></u></b></a></p><p class=3D"MsoNormalCxSpMiddle" style=3D=
"text-align:justify"><span style=3D"font-size:12.0pt;font-family:&quot;Time=
s New Roman&quot;,&quot;serif&quot;"><o:p>&nbsp;</o:p></span></p><p class=
=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span style=3D"font-s=
ize:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">Dear =
<b>Dr. XiangZhen Kong<a name=3D"_GoBack"></a>,<o:p></o:p></b></span></p><p =
class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span style=3D"f=
ont-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">=
<o:p>&nbsp;</o:p></span></p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-=
align:justify"><span style=3D"font-size:12.0pt;font-family:&quot;Times New =
Roman&quot;,&quot;serif&quot;">Hope you are doing well!<o:p></o:p></span></=
p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span style=
=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&qu=
ot;"><o:p>&nbsp;</o:p></span></p><p class=3D"MsoNormalCxSpMiddle" style=3D"=
text-align:justify"><span style=3D"font-size:12.0pt;font-family:&quot;Times=
 New Roman&quot;,&quot;serif&quot;">This is a follow up mail from the edito=
rial office of </span><b><u><span style=3D"font-size:16.0pt;font-family:&qu=
ot;Shonar Bangla&quot;,&quot;sans-serif&quot;">Research Advances in Brain D=
isorders and Therapy.</span></u></b><b><span style=3D"font-size:12.0pt;font=
-family:&quot;Times New Roman&quot;,&quot;serif&quot;"><o:p></o:p></span></=
b></p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span s=
tyle=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;seri=
f&quot;"><o:p>&nbsp;</o:p></span></p><p class=3D"MsoNormalCxSpMiddle" style=
=3D"text-align:justify"><span style=3D"font-size:12.0pt;font-family:&quot;T=
imes New Roman&quot;,&quot;serif&quot;">We have contacted you before throug=
h mail might be of technical problem you did not receive it, hence we are t=
aking liberty to reminding you once again regarding our previous invitation=
 to submit. We would be glad to know your opinion in submitting your manusc=
ript to the Inaugural Issue, 2018 of the journal, so we can plan accordingl=
y to include it in the same.<o:p></o:p></span></p><p class=3D"MsoNormalCxSp=
Middle" style=3D"text-align:justify"><span style=3D"font-size:12.0pt;font-f=
amily:&quot;Times New Roman&quot;,&quot;serif&quot;"><o:p>&nbsp;</o:p></spa=
n></p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span s=
tyle=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;seri=
f&quot;">Note: We expect your kind opinion please!<o:p></o:p></span></p><p =
class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span style=3D"f=
ont-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">=
<o:p>&nbsp;</o:p></span></p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-=
align:justify"><span style=3D"font-size:12.0pt;font-family:&quot;Times New =
Roman&quot;,&quot;serif&quot;">Please submit your manuscript online at </sp=
an><a href=3D"https://gavinpublishers.com/journals/submitmanuscript"><span =
style=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;ser=
if&quot;">https://gavinpublishers.com/journals/submitmanuscript</span></a><=
span style=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quo=
t;serif&quot;"><o:p></o:p></span></p><p class=3D"MsoNormalCxSpMiddle" style=
=3D"text-align:justify"><span style=3D"font-size:12.0pt;font-family:&quot;T=
imes New Roman&quot;,&quot;serif&quot;"><o:p>&nbsp;</o:p></span></p><p clas=
s=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><b><u><span style=3D=
"font-size:16.0pt;font-family:&quot;Shonar Bangla&quot;,&quot;sans-serif&qu=
ot;">All published articles will be provided with digital object identifier=
 (DOI).<o:p></o:p></span></u></b></p><p class=3D"MsoNormalCxSpMiddle" style=
=3D"text-align:justify"><span style=3D"font-size:12.0pt;font-family:&quot;T=
imes New Roman&quot;,&quot;serif&quot;"><o:p>&nbsp;</o:p></span></p><p clas=
s=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span style=3D"font-=
size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">Hope=
 I can hear your voice soon. Looking forward to hearing from you<o:p></o:p>=
</span></p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><s=
pan style=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot=
;serif&quot;"><o:p>&nbsp;</o:p></span></p><p class=3D"MsoNormalCxSpMiddle" =
style=3D"text-align:justify"><span style=3D"font-size:12.0pt;font-family:&q=
uot;Times New Roman&quot;,&quot;serif&quot;">Thanks &amp; Regards,<o:p></o:=
p></span></p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify">=
<span style=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&qu=
ot;serif&quot;">Lucy Charter | Editor<o:p></o:p></span></p><p class=3D"MsoN=
ormalCxSpMiddle" style=3D"text-align:justify"><span style=3D"font-size:12.0=
pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">Gavin Interna=
tional Conferences and Publishers Inc., <o:p></o:p></span></p><p class=3D"M=
soNormalCxSpMiddle" style=3D"text-align:justify"><span style=3D"font-size:1=
2.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">5911 Oak R=
idge Way,<o:p></o:p></span></p><p class=3D"MsoNormalCxSpMiddle" style=3D"te=
xt-align:justify"><span style=3D"font-size:12.0pt;font-family:&quot;Times N=
ew Roman&quot;,&quot;serif&quot;">Lisle, IL 60532, USA.<o:p></o:p></span></=
p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span style=
=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&qu=
ot;">Tel: &#43;1-630-397-0234,<o:p></o:p></span></p><p class=3D"MsoNormalCx=
SpMiddle" style=3D"text-align:justify;text-autospace:none"><span style=3D"f=
ont-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">=
Website: </span><a href=3D"http://gavinpublishers.com/"><span style=3D"font=
-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">htt=
p://gavinpublishers.com/</span></a><span class=3D"MsoHyperlink"><span style=
=3D"color:#0070C0"><o:p></o:p></span></span></p><p class=3D"MsoNormalCxSpMi=
ddle" style=3D"text-align:justify"><span style=3D"font-size:12.0pt;font-fam=
ily:&quot;Times New Roman&quot;,&quot;serif&quot;"><o:p>&nbsp;</o:p></span>=
</p><p class=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><b><span =
style=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;ser=
if&quot;">NOTE: If you are interested to join as Editor/Reviewer, kindly su=
bmit your CV.<o:p></o:p></span></b></p><p class=3D"MsoNormalCxSpMiddle" sty=
le=3D"text-align:justify"><span style=3D"font-size:12.0pt;font-family:&quot=
;Times New Roman&quot;,&quot;serif&quot;"><o:p>&nbsp;</o:p></span></p><p cl=
ass=3D"MsoNormalCxSpMiddle" style=3D"text-align:justify"><span style=3D"fon=
t-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;"><o=
:p>&nbsp;</o:p></span></p><p class=3D"MsoNormal"><b><span style=3D"font-siz=
e:10.0pt;font-family:&quot;Georgia&quot;,&quot;serif&quot;;color:black;back=
ground:white">Disclaimer<i>:</i></span></b><span class=3D"m-115249708746449=
5930gmail-m4099188765937942892apple-converted-space"><i><span style=3D"font=
-size:10.0pt;font-family:&quot;Georgia&quot;,&quot;serif&quot;;color:black;=
background:white">&nbsp;</span></i></span><span style=3D"font-size:10.0pt;f=
ont-family:&quot;Georgia&quot;,&quot;serif&quot;;color:black;background:whi=
te">You have received this email because of your eminence and expertise. Ho=
wever, if you do not want to receive any email in the future from</span><sp=
an class=3D"apple-converted-space"><b><span style=3D"font-size:10.0pt;font-=
family:&quot;Georgia&quot;,&quot;serif&quot;;color:#222222;background:white=
">&nbsp;</span></b></span><span style=3D"font-size:10.0pt;font-family:&quot=
;Georgia&quot;,&quot;serif&quot;">Research Advances in Brain Disorders and =
Therapy,<span class=3D"m-1152497087464495930gmail-apple-converted-space"><s=
pan style=3D"color:black;background:white">&nbsp;</span></span><span style=
=3D"color:black;background:white">then please reply us with the subject &qu=
ot;unsubscribe/remove&quot;.</span></span><span class=3D"MsoHyperlink"><spa=
n style=3D"font-size:10.0pt;color:windowtext;text-decoration:none"><o:p></o=
:p></span></span></p><p class=3D"MsoNormalCxSpLast" style=3D"text-align:jus=
tify"><span style=3D"font-size:12.0pt;font-family:&quot;Times New Roman&quo=
t;,&quot;serif&quot;"><o:p>&nbsp;</o:p></span></p></div></body></html>=

------=_NextPart_000_0078_01D38974.9E75AC80--

